What does the fracturing of vaccine recommendation and coverage imply for the U.S. well being care ecosystem? Will the potential head of the Facilities for Illness Management and Prevention stand as much as her boss? And might Amgen overcome its weight problems drug’s unwanted side effects?
We focus on all that and extra on this on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.
We invite STAT’s senior author for infectious ailments, Helen Branswell, and Washington correspondent Chelsea Cirruzzo on to the podcast to debate the newest information on the CDC. The company is within the highlight as soon as once more, after the Senate grilled the potential head of the company at a affirmation listening to and its federal vaccine advisory committee met for the primary time after Robert F. Kennedy Jr. fired its present 17 members and put in a brand new, smaller panel.
We additionally focus on the newest information within the life sciences, together with knowledge offered eventually weekend’s American Diabetes Affiliation analysis assembly. We additionally squeeze in some dialog about summer season blockbusters. (Try Adam’s “Jaws” Lego set right here).
To examine how vaccine coverage is fracturing, go right here; for extra on CDC nominee Susan Monarez’s affirmation listening to, go right here; for the newest on Amgen’s MariTide knowledge, go right here; and for the main points on Vertex’s diabetes cell remedy, go right here.
Make certain to join “The Readout LOUD” on Apple Podcasts, Spotify, or wherever you get your podcasts.
